Ventricular arrhythmias Clinical Trials

10 recruitingLast updated: May 21, 2026

There are 10 actively recruiting ventricular arrhythmias clinical trials across 11 countries. Studies span Not Applicable, Phase 3. Top locations include Toulouse, France, Paris, France, Massy, France. Updated daily from ClinicalTrials.gov.


Ventricular arrhythmias Trials at a Glance

10 actively recruiting trials for ventricular arrhythmias are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Toulouse, Paris, and Massy. Lead sponsors running ventricular arrhythmias studies include Centro Medico Teknon, Northwell Health, and Annetine Gelijns.

Browse ventricular arrhythmias trials by phase

About Ventricular arrhythmias Clinical Trials

Looking for clinical trials for Ventricular arrhythmias? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Ventricular arrhythmias trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Ventricular arrhythmias clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

Do QT-Prolonging Drugs Cause Major Adverse Cardiac Events in Hospitalized Adults?

Ventricular arrhythmiasMedication SafetyTorsades de Pointes+3 more
St. Joseph's Healthcare Hamilton990,000 enrolled2 locationsNCT07374263
Recruiting
Phase 3

Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm

Ventricular Arrhythmias and Cardiac Arrest
Versailles Hospital674 enrolled29 locationsNCT06835491
Recruiting
Phase 3

Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm

Ventricular arrhythmiasVentricular TachycardiaVentricular Fibrillation+1 more
Ottawa Heart Institute Research Corporation192 enrolled1 locationNCT06281977
Recruiting
Not Applicable

Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors

Chronic Lymphocytic LeukemiaAtrial FibrillationSupraventricular Arrhythmia+2 more
Northwell Health50 enrolled1 locationNCT05643235
Recruiting
Not Applicable

PRIMARY Ancillary Substudy

Ventricular arrhythmiasMitral valve prolapseLeft Ventricular Fibrosis
Annetine Gelijns250 enrolled25 locationsNCT07103733
Recruiting
Phase 3

Effect and Safety of Flecainide and Metoprolol Versus Metoprolol Alone to Suppress Ventricular Arrhythmias in Arrhythmic Mitral Valve Prolapse

Mitral valve prolapseVentricular Arrhythmias and Cardiac Arrest
Oslo University Hospital50 enrolled1 locationNCT05631730
Recruiting
Not Applicable

Evaluation of Electrocardiographic Measurements by High Density Electrode ECG

Ventricular arrhythmias
University Hospital, Bordeaux1,800 enrolled11 locationsNCT04921501
Recruiting

Hybrid Score to Predict OTVA-SOO in Patients with Wide Basal QRS

Ventricular arrhythmiasCatheter AblationECG
Centro Medico Teknon100 enrolled6 locationsNCT06602635
Recruiting

Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.

Left ventricular noncompactionHypertrophic Cardiomyopathy (HCM)Non-ischemic Cardiomyopathy+12 more
Scientific Institute San Raffaele15,000 enrolled1 locationNCT06607471
Recruiting
Not Applicable

"Right Ventricular Outflow Tract Posterior Septum Pacing" in Predicting Ventricular Outflow Tract Ventricular Tachycardia Origin

Ventricular Outflow Tract Ventricular ArrhythmiasRadio Frequency Catheter Ablation
Second Affiliated Hospital of Wenzhou Medical University100 enrolled1 locationNCT06360003